Skip to main content
. 2023 Oct 24;2023(10):CD013584. doi: 10.1002/14651858.CD013584.pub2

Gu 1999.

Study characteristics
Methods Prospective, randomised study
Accepted for publication: 13 July 1998
Number of study centres and location: single centre, Departments of Cardiothoracic Surgery and Anaesthesiology, University Hospital Groningen, Groningen, the Netherlands
Participants Forty cardiac surgical patients undergoing CPB were allocated randomly to a leucocyte depletion group (n = 20) and a control group (n = 20).
Mean age: 65.5 years
Sex (female/male ratio): 32.5%
No high‐risk patients
Inclusion criteria: undergoing CABG, heart valve replacement, or a combined procedure
Exclusion criteria: allergy, infection, or preoperative pulmonary dysfunction
Interventions Intervention group: leucocyte depletion was achieved with 2 filter sets (Pall Duplex filter sets (J1647G; Pall Biomedical, Portsmouth, UK)) located between the venous drainage and the venous reservoir and was driven by a separate roller pump of the heart‐lung machine. 
Leucocyte filtration was commenced after the start of rewarming but before the release of the aortic cross‐clamp.
Control group: no leucocyte depletion filter
Outcomes Mean Plt and leucocyte removal rate, inflammatory markers (IL‐8, elastase, L‐selectine), and clinical observations (postoperative PaO2 or pulmonary haemodynamics, postoperative intubation time and blood loss, urine output, length of stay in the ICU and in the hospital)
Blood samples from participants were taken from the radial arterial catheter before operation, at several points during CPB, at the end of CPB, at the end of operation during skin closure, 1 hour and 3 hours after transfer to the ICU, and at 6 a.m. the next morning in the ICU.
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk No randomisation method description: "The patients were allocated randomly to a leukocyte depletion group (n = 20) and a control group (n = 20)"
Allocation concealment (selection bias) Unclear risk No allocation concealment information
Blinding of participants and personnel (performance bias)
All outcomes Unclear risk Not specified; unlikely because of the nature of the intervention
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Not specified
Incomplete outcome data (attrition bias)
All outcomes Unclear risk Levels of inflammatory mediators were determined mainly during the postoperative course in exclusively 10 participants in each group, but unclear criteria of selection for the subgroup.
Selective reporting (reporting bias) Unclear risk All expected outcomes were reported properly.
Other bias High risk Sponsorship provided by Pall Biomedical UK